MHIPMilliman Healthcare Inflation Plus ETF
Seeks to exceed the U.S. healthcare cost inflation rate over time.
By Milliman · Launched 2026
Annual Cost
0.55%
#2,921 of 5,861 · average
Fund Size
$1.0M
#5,655 of 5,861 · small
Return (1Y)Goal
N/A
Track Record
4 months
#5,366 of 5,861 · young
Performance
Total-return NAV · USDGrowth of $10,000
$10,118+1.2%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 8 holdings = 40.4% of fundmoderately concentrated
BondBloxx Bloomberg FiveYrTrgDurUSTrsETFXFIV
11.5%
State Street® SPDR® Port S&P 500® ETFSPYM
8.8%
BondBloxx Bloomberg SixMthTrgDurUSTrsETFXHLF
4.5%
Eli Lilly and CoLLY
4.3%
UnitedHealth Group IncUNH
3.8%
Johnson & JohnsonJNJ
2.7%
Thermo Fisher Scientific IncTMO
2.6%
Abbott LaboratoriesABT
2.2%
Asset allocation
Stocks
62.9%
Cash
22.6%
Bonds
14.6%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-2.3%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Bond profile
Duration
3.3 years
Credit ratings
US Government
41.9%
AA
100.0%
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to exceed the U.S. healthcare cost inflation rate over time.
- Strategy
- Invests primarily in U.S.-listed common stocks, ADRs, and corporate bonds of healthcare companies, along with commodities and TIPS to hedge against healthcare cost inflation. Utilizes a proprietary quantitative model to adjust exposure based on inflation trends, maintaining higher equity levels during inflationary periods.
- Inception date
- April 20, 2026
- Fund family
- Milliman
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at MHIP. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04